MLYS ▲ +0.8% - Mineralys Therapeutics, Inc.
$MLYS - Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International
28-OCT-2026 07:05 AM ET
Share this post
More filings for $MLYS
MLYS ▲ +1.2% - Mineralys Therapeutics, Inc.Oct 28, 2026MLYS ▲ +7.4% - Mineralys Therapeutics, Inc.Oct 28, 2026MLYS ▲ +1.8% - Mineralys Therapeutics, Inc.Oct 22, 2026MLYS ▲ +3.1% - Mineralys Therapeutics, Inc.Oct 19, 2026MLYS ▼ -0.1% - Mineralys Therapeutics, Inc.Oct 9, 2026MLYS ▼ -0.4% - Mineralys Therapeutics, Inc.Oct 2, 2026
View full $MLYS filing history →💬 Comments
Loading comments…
Leave a comment